Completed NA INTERVENTIONAL 2-arm NCT01469676

Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function (PulmFunction)

Effects of CPB-leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function.

Sponsor: Fundação de Amparo à Pesquisa do Estado de São Paulo

Conditions Complications Due to Coronary Artery Bypass Graft Leukocyte Disorders Systemic Inflammatory Response Syndrome (SIRS)

Interventions Filtering group LG-6, Pall Biomedical Products

Updated 5 times since 2017 Last updated: Nov 9, 2011 Started: Feb 28, 2007 Primary completion: Feb 28, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Complications Due to Coronary Artery Bypass Graft and Leukocyte Disorders and is currently completed. Fundação de Amparo à Pesquisa do Estado de São Paulo leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundação de Amparo à Pesquisa do Estado de São Paulo
InCor Heart Institute
University of Sao Paulo

Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.